Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 5.104\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a N#CC12C(N)=NC3(OCCO3)C1(C#N)C1=C(CCC1)NC2c1ccccc1
b CCN(CC)c1ccc(/C=N/NC(=O)CNC(=O)c2ccc3c(c2)OCCO3)cc1
c Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
Answer: c. Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
4-methyl-N-[1-(morpholine-4-carbonyl)piperidin-4-yl]benzamide